Angiotensin II Promotes Glucose-Induced Activation of Cardiac Protein Kinase C Isozymes and Phosphorylation of Troponin I

Diabetes

Volumn 50, Issue 8, 2001, Pages 1918-1926

  Malhotra, Ashwani ^a   Kang, Barinder P S ^a   Cheung, Simon ^a   Opawumi, David ^a   Meggs, Leonard G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; 1,2-BIS(2-AMINOPHENOXY)ETHANE N,N,N',N'-TETRAACETIC ACID ACETOXYMETHYL ESTER; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRIDGED COMPOUND; CALCIUM; DRUG DERIVATIVE; EGTAZIC ACID; ENZYME INHIBITOR; GENISTEIN; GLUCOSE; ISOENZYME; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; THIOKETONE; TRICYCLODECANE 9 YL XANTHOGENATE; TRICYCLODECANE-9-YL-XANTHOGENATE; TROPONIN I;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CYTOSOL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HEART MUSCLE; HEART VENTRICLE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; RAT; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BRIDGED COMPOUNDS; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; CYTOSOL; EGTAZIC ACID; ENZYME ACTIVATION; ENZYME INHIBITORS; GENISTEIN; GLUCOSE; HEART VENTRICLES; ISOENZYMES; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; THIONES; TROPONIN I;

EID: 0035430525     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1918     Document Type: Article

References (51)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:77-986, 1993
2. Rodrignes B, Cam MC, McNeill JH: Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180:53-57, 1998
3. Rodrigues B, McNeill JH: The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26:913-922, 1992
4. Bell DHH: Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care 18:708-714, 1995
5. Rybin VO, Stienberg SF: Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 74:299-309, 1994
6. Gu X, Bishop SP: Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 75:926-931, 1994
7. Zou Y, Komuro I, Yamazaki T, Aikawa R, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Yazaki Y: Protein kinase C, but not tyrosine kinase or Ras, plays a critical role in angiotensin II-indnced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem 271:33592-33597, 1996
8. Qiu Y, Ping P, Tang X, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu W, Teschner S, Bolli R: Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ∈ is the isoform involved. J Clin Invest 101:2182-2198, 1998
9. Goto M, Cohen MV, Downey JM: The role of protein kinase C in ischemic preconditioning. Ann N Y Acad Sci 793:177-190, 1996
10. Steinberg SF, Goldberg M, Rybin VO: Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 27:141-153, 1995
11. Mochly-Rosen D: Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268:247-251, 1995
12. Xiang H, McNeill JH: Protein kinase C activity is altered in diabetic rat hearts. Biochem Binphys Res Commun 187:703-710, 1992
13. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform beta II and diacylglycorol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-11063, 1992
14. Malhotra A, Reich D, Nakouzi A, Sanghi V, Geenen DL, Buttrick PM: Experimental diabetes is associated with functional activation of protein kinase C∈ and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81:1027-1033, 1997
15. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47:1057-1067, 1995
16. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retinal circulation. Am J Physiol 265:E783-E793, 1993
17. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protcin kinase C pathway in diabetes and hypergalactocemia. Diabetes 43:1122-1129, 1994
18. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
19. Pfeiffer A, Schatz H: Diabetic microvascular complications and growth factors. Erp Clin Endocrinol Diabetes 103:7-14, 1995
20. Willams B: Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertens 13:477-486, 1995
21. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heat WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKCβ inhibitor. Science 272:728-731, 1996
22. Sechi LA, Griffin CA, Schambelan M: The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43:1179-1184, 1994
23. Fiordaliso F, Li B, Latini R, Sonenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 80:513-527, 2000
24. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin angiotensin system and decreases the Bcl-2-to-Bax ratio in the cell. J Clin Invest 101:1326-1342, 1998
25. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs L, Anversa P: Angiotensin II induces apoptosis in adult ventricular myocytes via a PKC-dcpendent mechanism. J Mol Cell Cardiol 29:859-870, 1997
26. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homey CJ, Anversa P: Regulation of angiotensin II receptors on ventricular myocyte after myocardial infarction in rats. Circ Res 72:1149-1162, 1993
27. Redaelli G, Malhotra A, Li B, Li P, Sonnenblick EH, Hofman PA, Anversa P: Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ Res 82:594-603, 1998
28. Saggin L, Gorza L, Ausoni S, Schiaffino S: Troponin I switching in the developing heart. J Biol Chem 27:16299-16302, 1989
29. DeSilva PE, Husain A, Smeby RR, Khairallah PA: Measurement of immunoreactive angiotensin peptides in rat tissue: some pitfalls in angiotensin II analysis. Anal Biochem 174:80-87, 1988
30. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
31. Goldberg M, Zhang HL, Steinberg SF: Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J Clin Invest 99:55-61, 1997
32. Takeishi Y, Jalili T, Ball NA, Walsh RA: Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 85:261-271, 1999
33. Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, Kang P, Malhotra A, Anversa P: Insulin-like growth factor-1 induces Mdm 2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch mediated apoptosis. Am J Pathol 154:567-580, 1999
34. Jideama NM, Noland TA Jr, Raynor RL, Blobe GC, Fabbro D, Kazanietz MG, Blumberg PM, Hannun YA, Kuo JF: Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem 271:23277-23283, 1996
35. Giles TD, Ouyang J, Kerut EK, Given MB, Allen GE, McIlwam EF, Greenberg SS: Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am J Physiol 274:H295-H307, 1998
36. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller II: Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 56:1737-1750, 1999
37. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL: Targeted overexpression of protein kinase Cβ2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A 94:9320-9325, 1997
38. Jiang T, Kuznetsov V, Pak E, Zhang H, Robinson RB, Steinberg SF: Thrombin receptor actions in neonatal rat ventricular myocytes. Circ Res 78:553-563, 1996
39. Sadoshima J, Izumo S: Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 12:1681-1692, 1993
40. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autoricne release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-984, 1993
41. Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation of the insulin receptor functional effects and characterization of phosphorylation sites. J Clin Invest 97:613-620, 1996
42. Milczarek GJ, Martinez J, Bowden T: p53 phosphorylation: biochemical and functional consequences. Life Sci 60:1-11, 1997
43. Liao DF, Monia B, Dean N, Berk BC: Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 272:6146-6150, 1997
44. Gschwendt M, Leibersperger H, Kittstein W, Marks F. Protein kinase C zeta and eta in murine epidermis: TPA induces down-regulation of PKC eta but not PKC zeta. FEBS Lett 307:151-155, 1992
45. Trilivas I, McDonough PM, Brown JH: Dissociation of protein kinase C redistribution from the phosphorylation of its substrates. J Biol Chem 266:8431-8438, 1991
46. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, King GL, Walsh RA: In vivo phosphorylation of cardiac troponin I by protein kinase Cβ2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 102:72-78, 1998
47. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, Yatani A, Robbins J, Dorn GW II: Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKC epsilon translocation. Circ Res 86:1173-1179, 2000
48. Gray MO, Karliner JS, Mochly-Rosen D: A selective ∈-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272:30945-30951, 1997
49. Dorn GW, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D: Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A 96:12798-12803, 1999
50. Nishio Y, Warren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB, Dennis JW, King GL: Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 96: 1759-1767, 1995
51. Koya D, Dennis JW, Warren CE, Takahara N, Schoen KJ, Nishio Y, Nakajima T, Lipes MA, King GL: Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice. FASEB J 13:2329-2337, 1999